Feipeng Xiao – Trademark Portfolio

Entity Type: 01

Feipeng Xiao holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BBYYAIYL. The owner is based in Wugang, Hunan.

No.29, Group 16, Mishan Village

Shuangpai Township

Wugang, Hunan 422400 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BBYYAIYL
BBYYAIYL
Registered 2024
BBYYAIYL
BBYYAIYL
Registered 2022

Trademark Classifications

Feipeng Xiao's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Feipeng Xiao have?

Feipeng Xiao has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Feipeng Xiao file in?

Feipeng Xiao files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Feipeng Xiao's most well-known trademarks?

Feipeng Xiao's registered trademark portfolio includes well-known marks such as BBYYAIYL. These are among 2 currently registered trademarks in the portfolio.

What is Feipeng Xiao's trademark registration success rate?

Feipeng Xiao has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.